The US Food and Drug Administration Vaccines and Related Biological Products Advisory Committee resoundingly supported creating a new “inter-pandemic” pathway for updating licensed prototype pandemic influenza vaccines given concerns about the possibility of a highly pathogenic avian influenza (HPAI) virus pandemic.
US FDA Advisors Urge Faster Movement, mRNA Consideration, In Updating Pandemic Flu Vaccines
The FDA’s vaccine advisory committee endorsed a new plan to update pandemic influenza vaccines “inter-pandemic,” but encouraged the agency to consider how to make the approach feasible for novel vaccine technologies.
